Lushang Freda Pharmaceutical Co.,Ltd. (SHA:600223)

SHA:600223 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	2,839	2,948	1,734	4,318	5,139	5,074
Cash & Short-Term Investments	2,839	2,948	1,734	4,318	5,139	5,074
Cash Growth	-12.42%	70.04%	-59.85%	-15.97%	1.27%	34.82%
Accounts Receivable	578.79	511.85	599.06	428.31	306.23	447.69
Other Receivables	48.13	21.22	3,052	1,307	1,226	400.42
Receivables	626.92	533.07	3,652	1,740	1,532	848.11
Inventory	537.41	558.71	525.44	46,047	48,204	46,665
Prepaid Expenses	-	-	-	491.91	608.15	449.64
Other Current Assets	183.02	104	73.85	3,032	3,187	6,080
Total Current Assets	4,186	4,144	5,984	55,629	58,670	59,117
Property, Plant & Equipment	1,188	1,192	1,203	1,382	1,345	1,201
Long-Term Investments	180.01	168.53	191.76	926.97	874.1	633.52
Goodwill	153.74	153.74	153.74	155.59	160.33	164.31
Other Intangible Assets	161.76	163.22	148.7	196.5	210.1	215.7
Long-Term Deferred Tax Assets	30.71	29.82	23.66	105.04	101.25	105.42
Long-Term Deferred Charges	88.59	91.11	53.96	52.34	40.51	44.1
Other Long-Term Assets	55.4	58.73	58.26	26.22	13.92	17.53
Total Assets	6,044	6,000	7,818	58,474	61,415	61,499
Accounts Payable	389.31	413.35	452.98	9,266	8,694	8,388
Accrued Expenses	62.39	136.53	127.32	1,003	948.47	727.27
Short-Term Debt	263.03	212.12	705.22	2,270	3,219	4,303
Current Portion of Long-Term Debt	63.72	12.51	790.34	3,222	2,307	2,738
Current Portion of Leases	-	9.21	8.16	5.68	1.99	-
Current Income Taxes Payable	39.34	16.35	9.52	26.59	18.81	95.91
Current Unearned Revenue	117.51	122.97	108.44	17,869	21,686	18,561
Other Current Liabilities	193.43	183.3	199.78	16,944	14,217	15,673
Total Current Liabilities	1,129	1,106	2,402	50,606	51,093	50,486
Long-Term Debt	-	44.55	665.04	2,215	3,751	4,427
Long-Term Leases	6.3	7.53	12.98	21.37	7.69	-
Long-Term Unearned Revenue	55.4	51.23	55.18	55.63	59.17	53.45
Long-Term Deferred Tax Liabilities	2.21	2.31	2.73	8.55	5.24	6.54
Other Long-Term Liabilities	-	-	-	-	-	7.95
Total Liabilities	1,193	1,212	3,138	52,907	54,916	54,981
Common Stock	1,017	1,017	1,017	1,017	1,009	1,009
Additional Paid-In Capital	612.86	612.86	612.51	617.8	616.38	40.68
Retained Earnings	2,526	2,475	2,385	2,082	2,202	2,130
Comprehensive Income & Other	-	-	0.29	0.33	900	900
Total Common Equity	4,156	4,105	4,015	3,717	4,727	4,080
Minority Interest	695.8	683.47	665.37	1,850	1,773	2,437
Shareholders' Equity	4,851	4,788	4,680	5,567	6,500	6,517
Total Liabilities & Equity	6,044	6,000	7,818	58,474	61,415	61,499
Total Debt	333.05	285.92	2,182	7,735	9,287	11,468
Net Cash (Debt)	2,505	2,662	-448.16	-3,417	-4,149	-6,394
Net Cash Per Share	2.45	2.62	-0.44	-3.01	-4.01	-6.31
Filing Date Shares Outstanding	1,017	1,017	1,017	1,017	1,009	1,009
Total Common Shares Outstanding	1,017	1,017	1,017	1,017	1,009	1,009
Working Capital	3,057	3,037	3,583	5,023	7,577	8,631
Book Value Per Share	4.09	4.04	3.95	3.66	3.79	3.15
Tangible Book Value	3,840	3,788	3,712	3,365	4,357	3,700
Tangible Book Value Per Share	3.78	3.73	3.65	3.31	3.43	2.77
Buildings	-	1,045	917	1,312	1,294	1,009
Machinery	-	681.06	620.81	604.52	551.66	436.84
Construction In Progress	-	16.12	131.36	72.95	40.99	247.05

Source: S&P Global Market Intelligence. Standard template. Financial Sources.